Rheumatic fever – new diagnostic criteria
More details
Hide details
Submission date: 2017-12-28
Final revision date: -0001-11-30
Acceptance date: 2018-02-26
Online publication date: 2018-02-28
Publication date: 2018-02-28
Reumatologia 2018;56(1):37–41
Rheumatic fever (RF) is an autoimmune disease associated with group A -hemolytic streptococcal infection, in the course of which the patient develops carditis, arthritis, chorea, subcutaneous nodules and erythema marginatum.
Rheumatic fever diagnosis is based on the Jones criteria, developed in 1944, then revised twice by the American Heart Association (AHA), in 1992 and recently in 2015.
The last revision of the Jones criteria consists mainly in the supplementation of the major criteria with echocardiographic examination, the introduction of a concept of subclinical carditis and the isolation of low, medium and high risk populations among the patients.
AHA recommends that all the patients with suspected RF undergo Doppler echocardiographic examination after the Jones criteria have been verified, even if no clinical signs of carditis are present.
Rutkowska-Sak L, Szczygielska I, Hernik E, et al. Gorączka reumatyczna wczoraj i dziś. Post Nauk Med 2011; suppl. 2: 39-43.
Zühlke L, Beaton A, Engel M, et al. Group A Streptococcus, acute rheumatic fever and rheumatic heart disease: epidemiology and clinical considerations. Curr Treat Options Cardiovasc Med 2017; 19: 1-23.
Undas A. Gorączka reumatyczna. In: Interna Szczeklika. Gajewski P (ed.). Medycyna Praktyczna, Kraków 2015; 355-357.
Gewitz M, Baltimore R, Tani L, et al. Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography: A Scientific Statement From the American Heart Association. Circulation 2015; 131: 1806-1818.
Webb R, Grant C, Harnden A. Acute rheumatic fever. BMJ 2015; 351: h3443.
Grzanka K, Kucharz E. Epidemiologia gorączki reumatycznej. Wiad Lek 2003; 7-8: 353-358.
Dajani AS, Ayoub E, Bierman FZ. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992; 268: 2069-2073.
Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease-an evidence-based guideline. Nat Rev Cardiol 2012; 7: 297-309.
Hryniewicz W, Albrecht P, Radzikowski A. Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego. Available at: http://www.antybiotyki.edu.pl/...; 50-56.
Esposito S, Bianchini S, Fastiggi M, et al. Geoepidemiological hints about Streptococcus pyogenes strains in relationship with acute rheumatic fever. Autoimmun Rev 2015; 14: 616-621.
Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011; 3: 67-84.
Mahfouz RA, Alawady WS, Salem AS. Ventricular dyssynchrony as a marker of latent carditis in children with acute rheumatic fever: A tissue Doppler imaging. Echocardiography 2017; 34: 1667-1673.
Beaton A, Aliku T, Dewyer A. Latent rheumatic heart disease: identifying the children at highest risk of unfavorable outcome. Circulation 2017; 136: 2233-2244.
Carapetis J, Parr J, Cherian T. Standardization of epidemiologic protocols for surveillance of post-streptococcal sequelae: acute rheumatic fever, rheumatic heart disease and acute post-streptococcal glomerulonephritis. Department of Health and Human Services, National Institutes of Health. Available at: https://www.niaidnihgov/topics....
de Faria Pereira BA, Rodrigues Belo A, da Silva NA. Febre reumática: atualização dos critérios de Jones à luz da revisão da American Heart Association – 2015. Revista Brasileira de Reumatologia 2017; 57: 364-368.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.